Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-04-25
1998-05-26
Mutzell, Paula R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, A61K 3818
Patent
active
057564566
ABSTRACT:
A method for activating the HER2 receptor comprising contacting a cell which expresses this receptor with SMDF polypeptides is discussed. A method for enhancing differentiation and/or proliferation of a cell using SMDF polypeptides is also disclosed. These methods may be performed in vitro or in vivo.
REFERENCES:
patent: 4968603 (1990-11-01), Slamon et al.
Plowman et al., Nature, vol. 366, pp. 473-475, 1993.
Corfas et al., "Differential Expression of ARIA Isoforms in Rat Brain" Neuron 14:103-115 (Jan. 1995).
Ho, W., et al., "Sensory and Motor Neuron-derived Factor" Journal of Biological Chemistry 270(24) :14523-14532 (Jun. 16, 1995).
Benveniste, E.N. et al., "Purification and characterization of a human T-lymphocyte-derived glial growth-promoting factor" Proc. Natl. Acad. Sci. 82:3930-3934 (1985).
Brockes et al., "Glial growth factor-like activity in Schwann Cell tumors" Annals of Neurology 20(3):317-322 (1986).
Brockes et al., "Purification and preliminary characterization of a glial growth factor from the bovine pituitary" Journal of Biological Chemistry 255(18):8374-8377 (1980).
Brockes, J., "Assay and isolation of glial growth factor from the bovine pituitary" Methods in Enzymology 147:217-225 (1987).
Carraway et al., "The erbB3 gene product is a receptor for heregulin" Journal of Biological Chemistry 269(19):14303-14306 (1994).
Cohen, J.A. et al., "Expression of the neu proto-oncogene by Schwann Cells during peripheral nerve development and Wallerian degeneration" J. Neuroscience Res. 31:622-634 (1992).
Corfas & Fischbach, "The number of Na.sup.+ channels in cultured chick muscle is increased by ARIA, an acetylcholine receptor-inducing activity" J. Neuroscience 13(5):2118-2125 (1993).
Danilenko et al., "Neu differentiation factor (NDF) accelerates epidermal migration and differentiation in excisional wounds"FASEB 8((4-5)):abst No. 3101, p. A535 (1994).
Davis & Stroobant, "Platelet-derived growth factors and Fibroblast growth factors are mitogens for rat Schwann Cells" Journal of Cell Biology 110:1353-1360 (1990).
Davis, JG et al., "Isolation and characterization of a neu protein-specific activating factor from human ATL-2 cell conditioned medium" Biochem. & Biophys. Res. Comm. 179(3):1536-1542 (Sep. 30, 1991).
De Corte et al., "A 50 kDa protein present in conditioned medium of COLO-16 cells stimulates cell spreading and motility, and activates tyrosine phosphorylation of Neu/HER-2, in human SK-BR-3 mammary cancer cells" J. Cell Science 107:405-416 (1994).
Dobashi, K., et al., "Characterization of a neu/c-erbB-2 protein-specific activating factor" Proc. Natl. Acad. Sci. 88:8582-8596 (Oct. 1991).
Falls et al., "ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the Neu ligand family" Cell 72:801-815 (1993).
Hoffman, Michelle, "New Clue Found to Oncogene's Role in Breast Cancer" Science 256:1129 (1992).
Holmes et al., "Identification of heregulin, a specific activator of p185.sup.erbB2 " Science 256: 1205-1210 (1992).
Kuo et al., "Isolation and characterization of chick and human nARIA, a novel member of the ERBB2/HER ligand family which lacks the immunoglobulin domain" Soc. Neuroscience Abst. 20:abst.452.18, p. 1095 (1994).
Lemke & Brockes, "Identification and purification of glial growth factor" J. Neurosci. 4(1):75-83 (1984).
Levi et al., "The functional characteristics of Schwann Cells cultured from human peripheral nerve after transplantation into a gap within the rat sciatic nerve" J. Neuroscience 14(3):1309-1319 (1994).
Lupu et al., "Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185.sup.erbB2 "Science 249:1552-1555 (1990).
Lupu et al., "Purification and Characterization of a Novel Growth Factor from Human Breast Cancer Cells" Biochemistry 31(32):7330-7340 (Aug. 1992).
Lupu et al., "Purification of a novel growth factor that binds exclusively to the erbB-2 receptor protein and induces cellular responses" Proc. Am. Assoc. Cancer Res. 32:abst. No. 297, p. 50 (1991).
Marchionni et al., "Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system" Nature 362:312-318 (1993).
Meyer & Birchmeier, "Distinct isoforms of neuregulin are expressed in mesenchymal and neuronal cells during mouse development" Proc. Natl. Acad. Sci. 91:1064-1068 (1994).
Nagata et al., "Solution structure of the epidermal growth factor-like domain of heregulin-.alpha., a ligand for p180.sup.erbB-4 " EMBO J. 13(15):3517-3523 (1994).
Orr-Urtreger et al., "Neural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21" Proc. Natl. Acad. Sci. 90:1867-1871 (1993).
Peles & Yarden, "Neu and its Ligands: From an Oncogene to Neural Factors" BioEssays 15(12):815-824 (1993).
Peles et al., "Cell-type interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships" EMBO Journal 12(3):961-971 (1993).
Peles, et al., "Isolation of the Neu/HER-2 Stimulatory Ligand: A 44 Kd Glycoprotein That Induces Differentiation of Mammary Tumor Cells" Cell 69(1):205-216 (Apr. 3, 1992).
Pinkas-Kramarski et al., "Brain neurons and glial cells express Neu differentiation factor/heregulin: A survival factor for astrocytes" Proc. Natl. Acad. Sci. USA 91:9387-9391 (1994).
Samanta et al., "Ligand and p185.sup.c-neu density govern receptor interactions and tyrosine kinase activation" Proc. Natl. Acad. Sci. 91:1711-1715 (1994).
Shah et al., "Glial growth factor restricts mammalian neural crest stem cells to a glial fate" Cell 77:349-360 (1994).
Sklar et al., "A novel growth factor for muscle-rhGGF2" J. Cell Biochem. abst:450, abst. W462 (1994).
Sliwkowski et al., "Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin" Journal of Biological Chemistry 269 (20):14661-14665 (1994).
Tarakhovsky, A. et al., "A 25 kDa polypeptide is the ligand for p185Neu and is secreted by activated macrophages" Oncogene 6(12);2187-2196 (Dec. 1991).
Wen et al., "Neu differentiation factor: a transmembrane glycoprotein containing an EGF Domain and an Immunoglobulin Homology Unit" Cell69(3):559-572 (May 1, 1992).
Wen et al., "Structural and functional aspects of the multiplicity of neu differentiation factors" Molecular & Cellular Biology 14(3):1909-1919 (1994).
Yang et al., "Identification of different ARIA splice variants expressed by chick CNS and PNS neurons during development" Soc. Neuroscience Abst. 20:abst. No. 452.17, p. 1095 (1994).
Yarden and Peles, "Biochemical Analysis of the Ligand for the neu Oncogenic Receptor" Biochemistry 30:3543-3550 (Nov. 1991).
Ho Wei-Hsien
Osheroff Phyllis L.
Genentech Inc.
Gucker Stephen
Lee Wendy M.
Mutzell Paula R.
LandOfFree
Methods involving sensory and motor neuron derived factor (SMDF) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods involving sensory and motor neuron derived factor (SMDF), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods involving sensory and motor neuron derived factor (SMDF) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1960047